A novel standard to evaluate the impact of therapeutic agents on patient safety – The BURDEN OF THERAPY™(©∗)

PURPOSE: Currently, treatment-emergent adverse events (TEAEs) during a clinical study are summarized over the entire study period. OBJECTIVE: Develop and validate a novel methodology, BURDEN OF THERAPY(©∗) (BOTh(©∗)), to quantify presence and severity of TEAEs on each day of study. METHODS: BOTh uti...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulahad, Ayad K., Snijder, Robert J., Panni, Moeen K., Riaz, Faysal K., Karas, Andreas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935900/
https://www.ncbi.nlm.nih.gov/pubmed/29736481
http://dx.doi.org/10.1016/j.conctc.2016.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935900/
https://www.ncbi.nlm.nih.gov/pubmed/29736481
http://dx.doi.org/10.1016/j.conctc.2016.09.003

Ejemplares similares